Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 732

1.

NEDD9 overexpression correlates with the progression and prognosis in gastric carcinoma.

Shi R, Wang L, Wang T, Xu J, Wang F, Xu M.

Med Oncol. 2014 Mar;31(3):852. doi: 10.1007/s12032-014-0852-4.

PMID:
24469954
2.

NEDD9 overexpression correlates with poor prognosis in gastric cancer.

Liu Y, Wang D, Zhao KL, Zhu JW, Yin HB, Wei YZ, Wu ZJ, Cheng GJ, Wang F, Ni F, Wang XL, Cao GX, Huang J, Cai J.

Tumour Biol. 2014 Jul;35(7):6351-6. doi: 10.1007/s13277-014-1839-7.

PMID:
24664584
3.

Expression of NEDD9 in pancreatic ductal adenocarcinoma and its clinical significance.

Xue YZ, Sheng YY, Liu ZL, Wei ZQ, Cao HY, Wu YM, Lu YF, Yu LH, Li JP, Li ZS.

Tumour Biol. 2013 Apr;34(2):895-9. doi: 10.1007/s13277-012-0624-8.

PMID:
23247867
4.

Aberrant SERCA3 expression is closely linked to pathogenesis, invasion, metastasis, and prognosis of gastric carcinomas.

Xu XY, Gou WF, Yang X, Wang GL, Takahashi H, Yu M, Mao XY, Takano Y, Zheng HC.

Tumour Biol. 2012 Dec;33(6):1845-54. doi: 10.1007/s13277-012-0444-x.

PMID:
22948776
5.

Upregulated expression of annexin II is a prognostic marker for patients with gastric cancer.

Zhang Q, Ye Z, Yang Q, He X, Wang H, Zhao Z.

World J Surg Oncol. 2012 Jun 8;10:103. doi: 10.1186/1477-7819-10-103.

6.

Overexpression of YAP1 is correlated with progression, metastasis and poor prognosis in patients with gastric carcinoma.

Hu X, Xin Y, Xiao Y, Zhao J.

Pathol Oncol Res. 2014 Oct;20(4):805-11. doi: 10.1007/s12253-014-9757-y.

PMID:
24643316
7.

Down-regulated SPARCL1 is associated with clinical significance in human gastric cancer.

Li P, Qian J, Yu G, Chen Y, Liu K, Li J, Wang J.

J Surg Oncol. 2012 Jan;105(1):31-7. doi: 10.1002/jso.22025.

PMID:
22161898
8.

Overexpression of Nedd9 is a prognostic marker of human gastric cancer.

Zhang Q, Wang H, Ma Y, Zhang J, He X, Ma J, Zhao ZS.

Med Oncol. 2014 Jul;31(7):33. doi: 10.1007/s12032-014-0033-5.

PMID:
24906654
9.

Abnormal expression of adhesion protein Bves is associated with gastric cancer progression and poor survival.

Luo D, Huang H, Lu ML, Zhao GF, Chang J, Zheng MY, Wang Y.

Pathol Oncol Res. 2012 Apr;18(2):491-7. doi: 10.1007/s12253-011-9472-x.

PMID:
22109561
10.
11.

Beclin 1 expression is an independent prognostic factor for gastric carcinomas.

Yu M, Gou WF, Zhao S, Xiao LJ, Mao XY, Xing YN, Takahashi H, Takano Y, Zheng HC.

Tumour Biol. 2013 Apr;34(2):1071-83. doi: 10.1007/s13277-013-0648-8.

PMID:
23334926
12.

Expression of NEDD9 in hepatocellular carcinoma and its clinical significance.

Lu P, Wang ZP, Dang Z, Zheng ZG, Li X, Zhou L, Ding R, Yue SQ, Dou KF.

Oncol Rep. 2015 May;33(5):2375-83. doi: 10.3892/or.2015.3863.

PMID:
25812772
13.

Serpin peptidase inhibitor clade A member 1 is a biomarker of poor prognosis in gastric cancer.

Kwon CH, Park HJ, Lee JR, Kim HK, Jeon TY, Jo HJ, Kim DH, Kim GH, Park DY.

Br J Cancer. 2014 Nov 11;111(10):1993-2002. doi: 10.1038/bjc.2014.490.

14.

The overexpression of AP-4 as a prognostic indicator for gastric carcinoma.

Xinghua L, Bo Z, Yan G, Lei W, Changyao W, Qi L, Lin Y, Kaixiong T, Guobin W, Jianying C.

Med Oncol. 2012 Jun;29(2):871-7. doi: 10.1007/s12032-011-9845-8.

PMID:
21336989
15.

Overexpression of KPNA2 correlates with poor prognosis in patients with gastric adenocarcinoma.

Li C, Ji L, Ding ZY, Zhang QD, Huang GR.

Tumour Biol. 2013 Apr;34(2):1021-6. doi: 10.1007/s13277-012-0641-7.

PMID:
23283818
16.

Prognostic significance of osteopontin expression in human gastric carcinoma.

Higashiyama M, Ito T, Tanaka E, Shimada Y.

Ann Surg Oncol. 2007 Dec;14(12):3419-27.

PMID:
17896150
17.

Myofibrillogenesis regulator-1 overexpression is associated with poor prognosis of gastric cancer patients.

Guo J, Dong B, Ji JF, Wu AW.

World J Gastroenterol. 2012 Oct 14;18(38):5434-41. doi: 10.3748/wjg.v18.i38.5434.

18.

Decreased expression of RASSF6 is a novel independent prognostic marker of a worse outcome in gastric cancer patients after curative surgery.

Wen Y, Wang Q, Zhou C, Yan D, Qiu G, Yang C, Tang H, Peng Z.

Ann Surg Oncol. 2011 Dec;18(13):3858-67. doi: 10.1245/s10434-011-1668-5.

PMID:
21442347
19.

An antiproliferative gene FLNA regulates migration and invasion of gastric carcinoma cell in vitro and its clinical significance.

Sun GG, Sheng SH, Jing SW, Hu WN.

Tumour Biol. 2014 Mar;35(3):2641-8. doi: 10.1007/s13277-013-1347-1.

PMID:
24241900
20.

Overexpression of minichromosome maintenance 2 predicts poor prognosis in patients with gastric cancer.

Yang C, Wen Y, Li H, Zhang D, Zhang N, Shi X, Jiang B, Ma X, Yang P, Tang H, Peng Z, Yang Y.

Oncol Rep. 2012 Jan;27(1):135-42. doi: 10.3892/or.2011.1473.

PMID:
21947329
Items per page

Supplemental Content

Support Center